Submitted by Anonymous (not verified) on 11 April 2025 - 16:40
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 25, Status: Authorised